21
May 2026
G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell. They communicate with nearly every physiological process in our bodies - from the ability to see and smell, to sensing of adrenaline, insulin, nutrients and medicines.
21
May 2026
Higher smartphone overdependence was significantly associated with greater odds of self-reported lifetime alcohol and tobacco use among more than 100,000 Korean adolescents. The study found graded dose-response patterns, with earlier initiation and heavier alcohol or smoking behaviors linked to a higher adjusted probability of high-risk smartphone overdependence.
21
May 2026
High-dose vitamin D3 supplementation from mid-pregnancy to early postpartum was associated with better verbal and visual memory in children at age 10. The post hoc analysis suggests prenatal vitamin D3 exposure may support selected cognitive functions, although findings require cautious interpretation.
21
May 2026
Scientists at the Garvan Institute of Medical Research have captured, for the first time, 'housekeeping' immune cells actively attacking and engulfing live melanoma cells – a discovery that could change the way we approach treatment for one of Australia's most common and deadly cancers.
21
May 2026
The Pan American Health Organization (PAHO) and The Carter Center signed a Technical Cooperation Agreement today to strengthen collaboration on the elimination of onchocerciasis — also known as river blindness — and other communicable diseases in the Americas.
21
May 2026
A new peer-reviewed publication published in Frontiers in Sports and Active Living, highlights bicycling as a powerful, accessible tool for improving brain health and overall well-being.
21
May 2026
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet recovery and helped patients with gastrointestinal cancers maintain platelet counts needed to continue chemotherapy as scheduled, according to results from a phase 2 clinical trial led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Mass General Hospital.
21
May 2026
A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment.
21
May 2026
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.
21
May 2026
Specific genetic fusion patterns in solitary fibrous tumors may help identify which patients face a higher risk of metastasis, recurrence and more aggressive disease behavior, according to new research that could improve how physicians assess and eventually treat this rare cancer.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
